Inventor
SWALLOW STEVEN
GB24 patents
⚠️ This page may combine multiple inventors who share the name “SWALLOW STEVEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTRAZENECA AB
18 patentsUS10287258B2May 14, 2019
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB18 citations97
US9815805B2Nov 14, 2017
Certain (25)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB22 citations97
US9522894B2Dec 20, 2016
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB25 citations97
US11773069B2Oct 3, 2023
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB6 citations94
US11117874B2Sep 14, 2021
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB15 citations93
US10669245B2Jun 2, 2020
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB16 citations93
US12054465B2Aug 6, 2024
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB3 citations85
US11814359B2Nov 14, 2023
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB4 citations85
US11680049B2Jun 20, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11673871B2Jun 13, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11673872B2Jun 13, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11667615B2Jun 6, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11655223B2May 23, 2023
Certain (2S)-N-[(1 s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11655221B2May 23, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11655224B2May 23, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11655222B2May 23, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations84
US9902731B2Feb 27, 2018
Chemical compounds
ASTRAZENECA AB2 citations70
US10202391B2Feb 12, 2019
Chemical compounds
ASTRAZENECA AB0 citations49
ROCHE PALO ALTO LLC
3 patentsUS7208509B2Apr 24, 2007
Non-nucleoside reverse transcriptase inhibitors
ROCHE PALO ALTO LLC26 citations92
US7189718B2Mar 13, 2007
Non-nucleoside reverse transcriptase inhibitors
ROCHE PALO ALTO LLC33 citations92
US7348345B2Mar 25, 2008
Nonnucleoside reverse transcriptase inhibitors
ROCHE PALO ALTO LLC8 citations74